AlphaFold predicted structure
MYOD1 · P15172

Mean pLDDT
61.2/ 100
Low
320 residues
Confidence breakdown
- Very high(≥ 90)21%
- Confident(70–90)7%
- Low(50–70)31%
- Very low(< 50)42%
AlphaFold (Jumper et al., 2021) · CC BY 4.0
myogenic differentiation 1
Annotations refreshed 9 hours ago.
Diagnostic Grade (Green)
Congenital myopathy
BIALLELIC, autosomal or pseudoautosomalFetal anomalies
BIALLELIC, autosomal or pseudoautosomalArthrogryposis
BIALLELIC, autosomal or pseudoautosomalmyopathy, congenital, with diaphragmatic defects, respiratory insufficiency, and dysmorphic facies
neurodegenerative disease
rhabdomyosarcoma
Hodgkins lymphoma
spindle cell rhabdomyosarcoma
embryonal rhabdomyosarcoma
fetal akinesia deformation sequence
cecum adenocarcinoma
gastric carcinoma
gastric adenocarcinoma
Score is the Open Targets composite evidence score (0-1). Higher = stronger gene-disease association.
Myoblast determination protein 1
Acts as a transcriptional activator that promotes transcription of muscle-specific target genes and plays a role in muscle differentiation. Together with MYF5 and MYOG, co-occupies muscle-specific gene promoter core region during myogenesis. Induces fibroblasts to differentiate into myoblasts. Interacts with and is inhibited by the twist protein. This interaction probably involves the basic domains of both proteins (By similarity)
MYOD1 · P15172

Mean pLDDT
61.2/ 100
Low
320 residues
Confidence breakdown
AlphaFold (Jumper et al., 2021) · CC BY 4.0